Inspire Medical Company Insiders

INSP Stock  USD 171.00  6.08  3.69%   
Inspire Medical's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Inspire Medical Systems suggests that virtually all insiders are panicking. Inspire Medical employs about 1.2 K people. The company is managed by 27 executives with a total tenure of roughly 137 years, averaging almost 5.0 years of service per executive, having 46.15 employees per reported executive.
Timothy Herbert  CEO
President, Chief Executive Officer, Director
Marilyn Nelson  Chairman
Independent Chairman of the Board

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-02-13Randy BanDisposed 25584 @ 183.5View
2025-02-11John RondoniDisposed 583 @ 170.49View
2025-01-07John RondoniDisposed 58 @ 215View
2024-09-09Shawn MccormickDisposed 800 @ 220View
2024-08-16Randy BanDisposed 4861 @ 188.55View
2024-04-17Richard BuchholzDisposed 15000 @ 230.03View
2024-04-01Timothy P HerbertDisposed 40000 @ 205.09View
2024-03-25Jerry C GriffinDisposed 554 @ 197.81View
Monitoring Inspire Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Inspire Medical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Inspire Medical's future performance. Based on our forecasts, it is anticipated that Inspire will maintain a workforce of slightly above 1250 employees by April 2025.
 
Covid

Inspire Medical Management Team Effectiveness

The company has return on total asset (ROA) of 0.0304 % which means that it generated a profit of $0.0304 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0848 %, meaning that it created $0.0848 on every $100 dollars invested by stockholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/24/2025, Return On Tangible Assets is likely to grow to 0.07. Also, Return On Capital Employed is likely to grow to 0.05. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 03/24/2025, Liabilities And Stockholders Equity is likely to grow to about 848.8 M, while Non Current Liabilities Total is likely to drop slightly above 24.2 M.
As of 03/24/2025, Common Stock Shares Outstanding is likely to drop to about 24 M. In addition to that, Net Loss is likely to drop to about (42.4 M)

Inspire Medical Workforce Comparison

Inspire Medical Systems is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 33,189. Inspire Medical holds roughly 1,246 in number of employees claiming about 4% of equities under Health Care industry.

Inspire Medical Profit Margins

The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.650.8468
Way Down
Slightly volatile

Inspire Medical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Inspire Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
0.6333
19
30
 116,751 
 76,490 
2024-12-01
0.5455
6
11
 9,042 
 151,888 
2024-09-01
0.5882
10
17
 43,381 
 60,349 
2024-06-01
1.0
18
18
 13,462 
 65,840 
2024-03-01
1.5667
47
30
 133,568 
 64,926 
2023-12-01
1.5556
14
9
 212,062 
 286,994 
2023-09-01
0.6
24
40
 32,136 
 269,542 
2023-06-01
0.7941
27
34
 29,332 
 40,736 
2023-03-01
0.6
24
40
 95,718 
 134,646 
2022-12-01
0.6667
16
24
 163,125 
 202,698 
2022-09-01
8.0
8
1
 10,274 
 6,218 
2022-06-01
1.4375
23
16
 42,787 
 111,520 
2022-03-01
0.5714
20
35
 188,079 
 418,864 
2021-12-01
1.2222
11
9
 20,523 
 58,485 
2021-09-01
1.0
10
10
 6,448 
 11,091 
2021-03-01
0.68
17
25
 70,439 
 113,354 
2020-12-01
0.4722
17
36
 209,965 
 153,125 
2020-09-01
0.3208
17
53
 84,334 
 1,082,679 
2020-06-01
0.76
19
25
 95,127 
 190,600 
2020-03-01
0.3043
14
46
 237,384 
 2,368,482 
2019-12-01
0.325
13
40
 167,459 
 408,857 
2019-09-01
0.2034
12
59
 77,109 
 723,394 
2019-06-01
0.3594
23
64
 338,210 
 806,481 
2019-03-01
0.1765
9
51
 39,169 
 3,122,720 
2018-12-01
0.6818
15
22
 465,108 
 3,692,223 
2018-06-01
0.7727
68
88
 19,811,609 
 122,858,621 
2012-06-01
2.1429
15
7
 258,274 
 256,425 
2012-03-01
0.5333
8
15
 151,375 
 346,479 
2011-12-01
1.3333
4
3
 300,000 
 5,751 
2011-09-01
0.3333
2
6
 29,998 
 68,829 
2011-06-01
2.0
12
6
 107,050 
 56,881 
2011-03-01
0.5
2
4
 12,750 
 23,770 
2010-12-01
0.2174
5
23
 35,000 
 604,519 
2010-06-01
1.0
16
16
 471,799 
 206,387 
2010-03-01
0.6571
23
35
 1,040,461 
 664,089 
2009-12-01
0.5
3
6
 113,333 
 154,642 
2009-09-01
0.5
13
26
 36,624 
 49,967 
2009-06-01
7.5
15
2
 879,166 
 9,218 
2009-03-01
0.5769
15
26
 1,656,622 
 79,964 
2008-12-01
0.7188
23
32
 591,373 
 2,530,213 
2008-09-01
0.4706
8
17
 24,255 
 43,711 
2008-06-01
1.0
9
9
 26,280 
 3,259 
2008-03-01
1.0
21
21
 483,496 
 182,711 
2007-12-01
0.5938
19
32
 507,958 
 396,672 
2007-09-01
1.5
9
6
 565,893 
 4,921 
2006-06-01
0.3
6
20
 72,000 
 84,000 
2006-03-01
1.0
3
3
 590,000 
 80,000 
2005-12-01
0.1667
4
24
 260,000 
 520,000 
2005-06-01
1.6667
5
3
 38,000 
 16,000 
2005-03-01
0.1875
3
16
 53,000 
 126,000 
2004-12-01
0.25
2
8
 69,979 
 139,958 
2004-06-01
2.3333
7
3
 111,000 
 52,000 
2004-03-01
1.0
3
3
 33,006 
 62,718 

Inspire Medical Notable Stakeholders

An Inspire Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Inspire Medical often face trade-offs trying to please all of them. Inspire Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Inspire Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Timothy HerbertPresident, Chief Executive Officer, DirectorProfile
Marilyn NelsonIndependent Chairman of the BoardProfile
Steven JandrichChief Compliance Officer, Vice President of Human ResourcesProfile
Randall BanSenior Vice President Global Sales and MarketingProfile
Richard BuchholzChief Financial OfficerProfile
Philip EbelingChief Operating OfficerProfile
Georgia GarinoisMelenikiotouIndependent DirectorProfile
Megan CPADirector ReportingProfile
Shawn McCormickIndependent DirectorProfile
Jerry GriffinIndependent DirectorProfile
Casey TanseyIndependent DirectorProfile
Gary EllisIndependent DirectorProfile
Dana MeadIndependent DirectorProfile
Shelley BroaderIndependent DirectorProfile
Joe SanderSVP SalesProfile
Bryan JDGeneral VPProfile
Martin AbramsVice ExperienceProfile
John RondoniChief OfficerProfile
Ivan LubogoSenior SalesProfile
Bryan PhillipsSenior Vice President Chief Compliance Officer, General Counsel, Company SecretaryProfile
Melissa MannChief OfficerProfile
Ezgi YagciVice RelationsProfile
Andreas HenkeExecutive EuropeProfile
Kathy SherwoodSenior AccessProfile
Carlton WeatherbyChief OfficerProfile
Georgia MelenikiotouIndependent DirectorProfile
MD FAAOSChief OfficerProfile

About Inspire Medical Management Performance

The success or failure of an entity such as Inspire Medical Systems often depends on how effective the management is. Inspire Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Inspire management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Inspire management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.07 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.07  0.07 
Return On Equity 0.08  0.08 

Inspire Medical Workforce Analysis

Traditionally, organizations such as Inspire Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Inspire Medical within its industry.

Inspire Medical Manpower Efficiency

Return on Inspire Medical Manpower

Revenue Per Employee644.3K
Revenue Per Executive29.7M
Net Income Per Employee42.9K
Net Income Per Executive2M
Working Capital Per Employee435.2K
Working Capital Per Executive20.1M

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.